Bioavailability, Generic Drugs and Marketing

The New Frontier in Drug Development: Understanding Biologics and Small Molecules

Cloudbyz

MARCH 5, 2024

Drug Resistance: For diseases like cancer and infectious diseases, the development of resistance to small molecule drugs can be a significant challenge, requiring ongoing research into combination therapies or new mechanisms of action. Enhancing bioavailability is often a key focus in the development of small molecule drugs.

Development

Development Drugs Manufacturing Immune Response

XPhyto Announces Drug Formulation Strategy and 2021 Milestones Innovation to Impact

The Pharma Data

JANUARY 27, 2021

The addition of in-house, scalable commercial drug manufacturing capability is expected to add significant value and optionality to XPhyto’s drug formulation business. In 2020, XPhyto reported significant advancements in four drug formulation development programs.

Drugs

Drugs Manufacturing Drug Delivery Production

Clinical Research Informer

The New Frontier in Drug Development: Understanding Biologics and Small Molecules

XPhyto Announces Drug Formulation Strategy and 2021 Milestones Innovation to Impact

Webinars

Stay Connected